Gates cash backs cervical cancer shots for poor

	Tweet

A non-profit organisation, with the help of cash from Microsoft Corp. founder Bill Gates, launched a five-year drive on Tuesday to get new cervical cancer vaccines to women in poor countries.

The international health group PATH, which plans to run pilot schemes in four countries, said there was an acute need for the vaccines in the developing world, where local health systems do not support routine Pap smears.

A quarter of a million women die of cervical cancer each year, most of them in the world’s poorest countries.

Two rival vaccines targeting the human papillomavirus (HPV), which causes the disease, are expected to debut in the coming months from Merck & Co. Inc. and GlaxoSmithKline Plc.

As a first step, PATH plans a programme of research in India, Peru, Uganda and Vietnam, with a $27.8 million grant from the Bill & Melinda Gates Foundation, studying the best way to use the vaccines.

PATH will help pilot introduction in the four countries, and both drugmakers have agreed to provide their vaccines to demonstration projects.

Merck’s product, Gardasil, is expected to be first to market, but Glaxo’s Cervarix is not far behind. Both target HPV, a sexually transmitted infection, but they vary in the number of strains they attack and the way they are manufactured.

Industry analysts expect both vaccines to become multibillion-dollar sellers on the back of sales in rich countries.

But developing countries are also a potentially important market for the manufacturers if they can secure large orders and financial backing from governments or charities in exchange for preferential prices.

RELATED STORIES:
New cervical cancer vaccine offers women 100% protection   Annual cervical cancer screening persists, despite recommended guidelines   Cervical cancer vaccine can protect men from HPV   How Medical Center Research Led to New Cervical Cancer Vaccine   Study determines costs of breast and cervical cancer detection among low-income women   Protein found to be the link missing between HPV infection and cervical cancer development   Obese women in Canada are less likely to be screened for cervical cancer   Eight virus types cause almost all cervical cancer   Cervical cancer drops, but disparities persist   FDA approval of Gardasil to prevent cervical cancer   Cervical cancer vaccine gives long protection   Hysterectomy for cervical cancer feasible in obese women   Singapore questions cervical cancer vaccine for teens   $11.5 Million Cervical Cancer Grant Awarded to UAB Cancer Center, Partners   Phenoxodiol Produces Anti-cancer Responses in Women with Cervical Cancer   HPV shot too costly for the Netherlands: study   Merck says US CDC endorses cervical cancer vaccine   HPV tests better for cervical screening - experts   Genetic Differences Help Protect Against Cervical Cancer   Researcher Finds Link Between Chlamydia and Cervical Cancer   Cervical cancer vaccines may cut need for screening   Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]